Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
653.11
+18.13 (2.86%)
At close: Nov 6, 2026, 4:00 PM EST
658.88
+5.77 (0.88%)
After-hours: Nov 6, 2026, 7:49 PM EST
Medpace Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,838 | 2,530 | 2,109 | 1,886 | 1,460 | 1,142 | |
Revenue Growth | 20.35% | 19.97% | 11.84% | 29.17% | 27.80% | 23.38% |
Cost of Revenue | 787.83 | 732.13 | 682.1 | 638.25 | 534.89 | 441.09 |
Gross Profit | 2,051 | 1,798 | 1,427 | 1,248 | 925.11 | 701.29 |
Selling, General & Admin | 192.7 | 197.56 | 180.18 | 161.35 | 131.4 | 108.42 |
Amortization of Goodwill & Intangibles | 0.7 | 0.95 | 1.44 | 2.2 | 3.35 | 5.11 |
Other Operating Expenses | 1,223 | 1,037 | 770.65 | 723.09 | 492.67 | 373.13 |
Operating Expenses | 1,443 | 1,263 | 980.09 | 910.77 | 646.41 | 502.67 |
Operating Income | 607.14 | 534.94 | 446.87 | 336.83 | 278.7 | 198.62 |
Interest Expense | - | - | - | -0.49 | -2.91 | -0.11 |
Interest & Investment Income | 19.17 | 12.78 | 25 | - | - | - |
Currency Exchange Gain (Loss) | -7.73 | -7.73 | -0.5 | -1.93 | 3.86 | 2.78 |
Other Non Operating Income (Expenses) | 8.41 | 2.39 | 4.55 | 1.27 | 3.21 | 0.56 |
EBT Excluding Unusual Items | 626.99 | 542.38 | 475.92 | 335.68 | 282.86 | 201.85 |
Pretax Income | 626.99 | 542.38 | 475.92 | 335.68 | 282.86 | 201.85 |
Income Tax Expense | 109.17 | 91.25 | 71.54 | 52.87 | 37.49 | 20 |
Net Income | 517.83 | 451.12 | 404.39 | 282.81 | 245.37 | 181.85 |
Preferred Dividends & Other Adjustments | - | - | 0.04 | 0.19 | 0.16 | 0.46 |
Net Income to Common | 517.83 | 451.12 | 404.34 | 282.62 | 245.21 | 181.39 |
Net Income Growth | 19.61% | 11.57% | 43.07% | 15.25% | 35.18% | 25.16% |
Shares Outstanding (Basic) | 28 | 29 | 31 | 31 | 32 | 36 |
Shares Outstanding (Diluted) | 29 | 30 | 32 | 32 | 34 | 38 |
Shares Change | -5.07% | -7.77% | 0.54% | -5.44% | -10.68% | -0.03% |
EPS (Basic) | 18.36 | 15.64 | 13.06 | 9.20 | 7.57 | 5.06 |
EPS (Diluted) | 18.03 | 15.28 | 12.63 | 8.88 | 7.28 | 4.81 |
EPS Growth | 25.93% | 20.98% | 42.23% | 21.98% | 51.35% | 25.26% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 667.63 | 681.87 | 572.27 | 396.73 | 351.17 | 235.06 |
Free Cash Flow Per Share | 23.25 | 23.09 | 17.88 | 12.46 | 10.43 | 6.24 |
Gross Margin | 72.24% | 71.06% | 67.66% | 66.16% | 63.36% | 61.39% |
Operating Margin | 21.39% | 21.14% | 21.19% | 17.86% | 19.09% | 17.39% |
Profit Margin | 18.24% | 17.83% | 19.17% | 14.99% | 16.79% | 15.88% |
Free Cash Flow Margin | 23.52% | 26.95% | 27.13% | 21.04% | 24.05% | 20.58% |
EBITDA | 634.46 | 563.06 | 476.12 | 363.15 | 301.04 | 219.73 |
EBITDA Margin | 22.35% | 22.25% | 22.57% | 19.26% | 20.62% | 19.23% |
D&A For EBITDA | 27.33 | 28.12 | 29.25 | 26.33 | 22.34 | 21.12 |
EBIT | 607.14 | 534.94 | 446.87 | 336.83 | 278.7 | 198.62 |
EBIT Margin | 21.39% | 21.14% | 21.19% | 17.86% | 19.09% | 17.39% |
Effective Tax Rate | 17.41% | 16.83% | 15.03% | 15.75% | 13.26% | 9.91% |
Advertising Expenses | - | 1.5 | 1.5 | 1.5 | 1.3 | 1.2 |